Neurocrine Biosciences (NBIX) Net Income (2009 - 2026)
Neurocrine Biosciences (NBIX) posted Net Income of $206.5 million for Q3 2026, down 1.4% from $209.5 million a year earlier but up 43.0% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Net Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Income at Neurocrine Biosciences was $702.5 million, up 64.1% year-over-year; for FY2025, it was $478.6 million, up 40.2% from FY2024.
- Annual Net Income has increased for four consecutive years, with a five-year compound annual growth rate of 3.3% (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' Net Income was $341.3 million in FY2024 (+36.7%), $249.7 million in FY2023 (+61.6%), $154.5 million in FY2022 (+72.4%) and $89.6 million in FY2021 (-78.0%).
- Quarterly Net Income has run from a low of -$76.6 million in Q1 2023 to a high of $209.5 million in Q3 2025 over five years.
- On a year-over-year basis, Net Income increased in four of the last seven quarters, with growth averaging 13.8%.
- The strongest year-over-year quarter for Net Income in the past five years was Q3 2022, with growth of 204.4%; the weakest was Q1 2025, with a decline of 81.8%.
- According to Business Quant data, Net Income for the three prior quarters was $144.4 million (Q2 2026), $197.9 million (Q1 2026) and $153.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 206.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 206.50 Mn |
| Jun 30, 2026 | 144.40 Mn |
| Mar 31, 2026 | 197.90 Mn |
| Dec 31, 2025 | 153.70 Mn |
| Sep 30, 2025 | 209.50 Mn |
| Jun 30, 2025 | 107.50 Mn |
| Mar 31, 2025 | 7.90 Mn |
| Dec 31, 2024 | 103.10 Mn |
| Sep 30, 2024 | 129.80 Mn |
| Jun 30, 2024 | 65.00 Mn |
| Mar 31, 2024 | 43.40 Mn |
| Dec 31, 2023 | 147.70 Mn |
| Sep 30, 2023 | 83.10 Mn |
| Jun 30, 2023 | 95.50 Mn |
| Mar 31, 2023 | -76.60 Mn |
| Dec 31, 2022 | 89.00 Mn |
| Sep 30, 2022 | 68.50 Mn |
| Jun 30, 2022 | -16.90 Mn |
| Mar 31, 2022 | 13.90 Mn |
| Dec 31, 2021 | -7.30 Mn |
API Access
Neurocrine Biosciences Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();